Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Lung Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Chordoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Advanced Solid Malignancies 1 Advanced Liver Cancers 1

Interventions

Etoposide 31 Carboplatin 30 atezolizumab 18 durvalumab 16 Cisplatin 14 Topotecan 11 PM 01183 11 Specimen Handling 9 pembrolizumab 8 Magnetic Resonance Spectroscopy 7 olaparib 5 Radiotherapy 5 berzosertib 4 anlotinib 4 Paclitaxel 4 Nivolumab 4 Irinotecan 4 Drug Therapy 4 tremelimumab 3 toripalimab 3 tislelizumab 3 Temozolomide 3 Radiosurgery 3 Injections 3 Docetaxel 3 Biopsy 3 Bevacizumab 3 AMG 757 3 sacituzumab govitecan 2 monalizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Small Cell Lung Carcinoma × Tiragolumab × 90 days × Clear all

NCT04256421 2026-04-03

SKYSCRAPER-02

Hoffmann-La Roche

Phase 3 Completed

490 enrolled 33 charts

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡